Vimarsana
Biggest News Aggregation in the World

Ception Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ception Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ception Therapeutics Today - Breaking & Trending Today

Benralizumab reduces eosinophils but does not improve eosinophilic gastritis - Vimarsana News

Benralizumab reduces eosinophils but does not improve eosinophilic gastritis

Treatment with benralizumab induced histological remission, defined as an absence of tissue eosinophilia, among patients with eosinophilic gastritis, according to a study published in The Lancet Gastroenterology & Hepatology.But the persistence of signs, symptoms and biomarkers of the disease during treatment suggested a pathogenic mechanism independent of eosinophil levels in many patients,

Source: healio.com
Growing geriatric population will boost the eosinophilic esophagitis drug market, forecast to reach - Vimarsana News

Growing geriatric population will boost the eosinophilic esophagitis drug market, forecast to reach

Search jobs 12-Mar-2021 Growing geriatric population will boost the eosinophilic esophagitis drug market, forecast to reach US$ 135 Mn by 2025 with a CAGR of 6% Noida, Uttar Pradesh, India, March 12 2021 (Wiredrelease) Report Ocean Pvt Ltd –:The growing geriatric population, rising demand for early detection of diseases, and increasing prevalence of target diseases are key factors driving the market’s growth. The overall market for eosinophilic esophagitis drugs is also witnessing a surge in demand owing to increasing point-of-care testing and ...